speb/financial-data huggingface dataset:
MD income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 7280000.00
MD balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 1393584000.00
MD cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 54728000.00
MD balance_sheet (annual, 2021-12-31) — Minority Interest: 205000.00
MD income_statement (annual, 2021-12-31) — Minority Interests: 27000.00
MD income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 22950000.00
MD cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
MD cash_flow (annual, 2021-12-31) — Operating Gains Losses: 7252000.00
MD income_statement (annual, 2021-12-31) — Other Special Charges: 14532000.00
MD cash_flow (annual, 2021-12-31) — Sale Of Business: 24728000.00
MD cash_flow (annual, 2021-12-31) — Sale Of PPE: 24728000.00
MD cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
MD cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
MD income_statement (annual, 2022-12-31) — +Operating Expense: 267033000.00
MD income_statement (annual, 2022-12-31) — +Total Revenue: 1972021000.00
MD balance_sheet (annual, 2022-12-31) — Accounts Payable: 31857000.00
MD balance_sheet (annual, 2022-12-31) — Accounts Receivable: 296787000.00
MD balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -172218000.00
MD balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 983601000.00
MD balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1251705000.00
MD cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
MD income_statement (annual, 2022-12-31) — Basic Average Shares: 82947000.00
MD income_statement (annual, 2022-12-31) — Basic EPS: 0.80
MD cash_flow (annual, 2022-12-31) — Beginning Cash Position: 387391000.00
MD balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 8286000.00
MD cash_flow (annual, 2022-12-31) — Capital Expenditure: -29708000.00
MD balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 76930000.00
MD balance_sheet (annual, 2022-12-31) — Capital Stock: 829000.00
MD balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9824000.00
MD balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 103063000.00
MD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -487554000.00
MD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -56954000.00
MD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 182312000.00
MD cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: 0.00
MD cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: 0.00
MD cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: -15371000.00
MD cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 17196000.00
MD cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -14399000.00
MD cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 18225000.00
MD cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 420000.00
MD cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 15928000.00
MD cash_flow (annual, 2022-12-31) — Change In Receivables: -5543000.00
MD cash_flow (annual, 2022-12-31) — Change In Working Capital: 31827000.00
MD cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -5543000.00
MD cash_flow (annual, 2022-12-31) — Changes In Cash: -377567000.00
MD balance_sheet (annual, 2022-12-31) — Common Stock: 829000.00
MD balance_sheet (annual, 2022-12-31) — Common Stock Equity: 891632000.00
MD cash_flow (annual, 2022-12-31) — Common Stock Issuance: 5396000.00
MD cash_flow (annual, 2022-12-31) — Common Stock Payments: -88511000.00
MD income_statement (annual, 2022-12-31) — Cost Of Revenue: 1504988000.00
MD balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 307385000.00
MD balance_sheet (annual, 2022-12-31) — Current Assets: 427989000.00
MD balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 23987000.00
MD balance_sheet (annual, 2022-12-31) — Current Debt: 12500000.00
MD balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 36487000.00
MD balance_sheet (annual, 2022-12-31) — Current Liabilities: 426983000.00
MD cash_flow (annual, 2022-12-31) — Deferred Income Tax: -22771000.00
MD cash_flow (annual, 2022-12-31) — Deferred Tax: -22771000.00
MD cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 35636000.00
MD income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 35636000.00
MD cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 35636000.00
MD income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 35636000.00
MD income_statement (annual, 2022-12-31) — Diluted Average Shares: 84121000.00
MD income_statement (annual, 2022-12-31) — Diluted EPS: 0.79
MD income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 66335000.00
MD income_statement (annual, 2022-12-31) — EBIT: 121065000.00
MD income_statement (annual, 2022-12-31) — EBITDA: 156701000.00
MD income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 1722000.00
MD cash_flow (annual, 2022-12-31) — End Cash Position: 9824000.00
MD cash_flow (annual, 2022-12-31) — Financing Cash Flow: -487554000.00
MD cash_flow (annual, 2022-12-31) — Free Cash Flow: 137233000.00
MD cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
MD cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
MD income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
MD income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
MD income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3671000.00
MD balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -3735000.00
MD income_statement (annual, 2022-12-31) — General And Administrative Expense: 231397000.00
MD balance_sheet (annual, 2022-12-31) — Goodwill: 1532092000.00
MD balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1550583000.00
MD balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1548492000.00
MD balance_sheet (annual, 2022-12-31) — Gross PPE: 312432000.00
MD income_statement (annual, 2022-12-31) — Gross Profit: 467033000.00
MD income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
MD cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 26908000.00
MD balance_sheet (annual, 2022-12-31) — Income Tax Payable: 16271000.00
MD income_statement (annual, 2022-12-31) — Interest Expense: 39695000.00
MD income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 39695000.00
MD cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 116235000.00
MD balance_sheet (annual, 2022-12-31) — Interest Payable: 8921000.00
MD balance_sheet (annual, 2022-12-31) — Invested Capital: 1531783000.00
MD cash_flow (annual, 2022-12-31) — Investing Cash Flow: -56954000.00
MD cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 5396000.00
MD cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1480000000.00
MD balance_sheet (annual, 2022-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 52943000.00
MD balance_sheet (annual, 2022-12-31) — Long Term Debt: 627651000.00
MD balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 680594000.00
MD cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1480000000.00
MD cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1885171000.00
MD balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
MD income_statement (annual, 2022-12-31) — Minority Interests: 4000.00
MD cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -28167000.00
MD cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -83115000.00
MD balance_sheet (annual, 2022-12-31) — Net Debt: 630327000.00
MD income_statement (annual, 2022-12-31) — Net Income: 66335000.00
MD income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 66335000.00
MD income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 62564000.00
MD income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 3767000.00
MD income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 66335000.00
MD income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 62568000.00
MD cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 62568000.00
MD income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 66331000.00
MD income_statement (annual, 2022-12-31) — Net Interest Income: -39695000.00
MD cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -457000.00
MD cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -405171000.00
MD cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -405171000.00
MD income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -39695000.00
MD cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 732000.00
MD cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1378000.00
MD balance_sheet (annual, 2022-12-31) — Net PPE: 140214000.00
MD cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -29708000.00
MD balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -658951000.00
MD balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 105925000.00
MD balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 33638000.00
MD balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 105925000.00
MD balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 33638000.00
MD income_statement (annual, 2022-12-31) — Normalized EBITDA: 237358000.00
MD income_statement (annual, 2022-12-31) — Normalized Income: 124593233.00
MD cash_flow (annual, 2022-12-31) — Operating Cash Flow: 166941000.00
MD cash_flow (annual, 2022-12-31) — Operating Gains Losses: 57016000.00
MD income_statement (annual, 2022-12-31) — Operating Income: 200000000.00
MD income_statement (annual, 2022-12-31) — Operating Revenue: 1951749000.00
MD balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 82947000.00
MD balance_sheet (annual, 2022-12-31) — Other Current Assets: 13261000.00
MD balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 12500000.00
MD balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -3735000.00
MD income_statement (annual, 2022-12-31) — Other Gand A: 231397000.00
MD income_statement (annual, 2022-12-31) — Other Income Expense: -78935000.00
MD balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 18491000.00
MD cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1909000.00
MD balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 123176000.00
MD balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 315040000.00
MD balance_sheet (annual, 2022-12-31) — Other Properties: 302114000.00
MD balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 93239000.00
MD income_statement (annual, 2022-12-31) — Other Special Charges: 57016000.00
MD balance_sheet (annual, 2022-12-31) — Payables: 83111000.00
MD balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 390496000.00
MD balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
MD balance_sheet (annual, 2022-12-31) — Prepaid Assets: 14878000.00
MD income_statement (annual, 2022-12-31) — Pretax Income: 81370000.00
MD balance_sheet (annual, 2022-12-31) — Properties: 0.00
MD cash_flow (annual, 2022-12-31) — Purchase Of Business: -28167000.00
MD cash_flow (annual, 2022-12-31) — Purchase Of Investment: -17346000.00
MD cash_flow (annual, 2022-12-31) — Purchase Of PPE: -29708000.00
MD balance_sheet (annual, 2022-12-31) — Receivables: 296787000.00
MD income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1504988000.00
MD income_statement (annual, 2022-12-31) — Reconciled Depreciation: 35636000.00
MD cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1885171000.00
MD cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -88511000.00
MD income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 27312000.00
MD balance_sheet (annual, 2022-12-31) — Retained Earnings: -89063000.00
MD cash_flow (annual, 2022-12-31) — Sale Of Investment: 16889000.00
MD cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
MD income_statement (annual, 2022-12-31) — Selling General And Administration: 231397000.00
MD balance_sheet (annual, 2022-12-31) — Share Issued: 82947000.00
MD income_statement (annual, 2022-12-31) — Special Income Charges: -84328000.00
MD cash_flow (annual, 2022-12-31) — Stock Based Compensation: 16127000.00
MD balance_sheet (annual, 2022-12-31) — Stockholders Equity: 891632000.00
MD balance_sheet (annual, 2022-12-31) — Tangible Book Value: -658951000.00
MD income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -18631767.00
MD income_statement (annual, 2022-12-31) — Tax Provision: 18806000.00
MD income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
MD balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
MD balance_sheet (annual, 2022-12-31) — Total Assets: 2347887000.00
MD balance_sheet (annual, 2022-12-31) — Total Capitalization: 1519283000.00
MD balance_sheet (annual, 2022-12-31) — Total Debt: 717081000.00
MD balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 891632000.00
MD income_statement (annual, 2022-12-31) — Total Expenses: 1772021000.00
MD balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1456255000.00
MD balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1919898000.00
MD balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1029272000.00
MD income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 172688000.00
MD balance_sheet (annual, 2022-12-31) — Total Tax Payable: 51254000.00
MD income_statement (annual, 2022-12-31) — Total Unusual Items: -80657000.00
MD income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -80657000.00
MD balance_sheet (annual, 2022-12-31) — Working Capital: 1006000.00
MD income_statement (annual, 2022-12-31) — Write Off: 0.00
MD income_statement (annual, 2023-12-31) — +Operating Expense: 263713000.00
MD income_statement (annual, 2023-12-31) — +Total Revenue: 1994640000.00
MD balance_sheet (annual, 2023-12-31) — Accounts Payable: 34588000.00
MD balance_sheet (annual, 2023-12-31) — Accounts Receivable: 272313000.00
MD balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -142715000.00
MD balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 999906000.00
MD balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1106900000.00
MD cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 168312000.00
MD income_statement (annual, 2023-12-31) — Basic Average Shares: 84018023.00
MD income_statement (annual, 2023-12-31) — Basic EPS: -0.72
MD cash_flow (annual, 2023-12-31) — Beginning Cash Position: 9824000.00
MD balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 8286000.00
MD cash_flow (annual, 2023-12-31) — Capital Expenditure: -33328000.00
MD balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 77555000.00
MD balance_sheet (annual, 2023-12-31) — Capital Stock: 840000.00
MD balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 73258000.00
MD balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 177743000.00
MD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -25715000.00
MD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -48176000.00
MD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 146081000.00
MD cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 0.00
MD cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 0.00
MD cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -8756000.00
MD cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 22851000.00
MD cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -27671000.00
MD cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -21677000.00
MD cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -11921000.00
MD cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 514000.00
MD cash_flow (annual, 2023-12-31) — Change In Receivables: 26276000.00
MD cash_flow (annual, 2023-12-31) — Change In Working Capital: -11628000.00
MD cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 26276000.00
MD cash_flow (annual, 2023-12-31) — Changes In Cash: 63434000.00
MD balance_sheet (annual, 2023-12-31) — Common Stock: 840000.00
MD balance_sheet (annual, 2023-12-31) — Common Stock Equity: 849061000.00
MD cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4912000.00
MD cash_flow (annual, 2023-12-31) — Common Stock Payments: -919000.00
MD income_statement (annual, 2023-12-31) — Cost Of Revenue: 1573075000.00
MD balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 279665000.00
MD balance_sheet (annual, 2023-12-31) — Current Assets: 483454000.00
MD balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 23489000.00
MD balance_sheet (annual, 2023-12-31) — Current Debt: 12500000.00
MD balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 35989000.00
MD balance_sheet (annual, 2023-12-31) — Current Liabilities: 388946000.00
MD cash_flow (annual, 2023-12-31) — Deferred Income Tax: 3239000.00
MD cash_flow (annual, 2023-12-31) — Deferred Tax: 3239000.00
MD cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 36171000.00
MD income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 36171000.00
MD cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 36171000.00
MD income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 36171000.00
MD income_statement (annual, 2023-12-31) — Diluted Average Shares: 84018023.00
MD income_statement (annual, 2023-12-31) — Diluted EPS: -0.73
MD income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -60408000.00
MD income_statement (annual, 2023-12-31) — EBIT: -6284000.00
MD income_statement (annual, 2023-12-31) — EBITDA: 29887000.00
MD income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 2057000.00
MD cash_flow (annual, 2023-12-31) — End Cash Position: 73258000.00
MD cash_flow (annual, 2023-12-31) — Financing Cash Flow: -25715000.00
MD cash_flow (annual, 2023-12-31) — Free Cash Flow: 103997000.00
MD cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
MD cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
MD income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
MD income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
MD income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 4338000.00
MD balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2214000.00
MD income_statement (annual, 2023-12-31) — General And Administrative Expense: 227542000.00
MD balance_sheet (annual, 2023-12-31) — Goodwill: 1384166000.00
MD balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1405406000.00
MD balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1379213000.00
MD balance_sheet (annual, 2023-12-31) — Gross PPE: 288648000.00
MD income_statement (annual, 2023-12-31) — Gross Profit: 421565000.00
MD income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 148312000.00
MD cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 30835000.00
MD balance_sheet (annual, 2023-12-31) — Income Tax Payable: 2159000.00
MD income_statement (annual, 2023-12-31) — Interest Expense: 42075000.00
MD income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 42075000.00
MD cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 42278000.00
MD balance_sheet (annual, 2023-12-31) — Interest Payable: 8262000.00
MD balance_sheet (annual, 2023-12-31) — Invested Capital: 1473154000.00
MD cash_flow (annual, 2023-12-31) — Investing Cash Flow: -48176000.00
MD cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4912000.00
MD cash_flow (annual, 2023-12-31) — Issuance Of Debt: 470000000.00
MD balance_sheet (annual, 2023-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 54066000.00
MD balance_sheet (annual, 2023-12-31) — Long Term Debt: 611593000.00
MD balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 665659000.00
MD cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 470000000.00
MD cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -489118000.00
MD income_statement (annual, 2023-12-31) — Minority Interests: 0.00
MD cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -6667000.00
MD cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 3993000.00
MD balance_sheet (annual, 2023-12-31) — Net Debt: 550835000.00
MD income_statement (annual, 2023-12-31) — Net Income: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
MD income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -60408000.00
MD cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -60408000.00
MD income_statement (annual, 2023-12-31) — Net Interest Income: -42075000.00
MD cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -8988000.00
MD cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -19118000.00
MD cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -19118000.00
MD income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -42075000.00
MD cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -10590000.00
MD cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 807000.00
MD balance_sheet (annual, 2023-12-31) — Net PPE: 145933000.00
MD cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -33328000.00
MD balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -556345000.00
MD balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 102852000.00
MD balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 34308000.00
MD balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 102852000.00
MD balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 34308000.00
MD income_statement (annual, 2023-12-31) — Normalized EBITDA: 196080000.00
MD income_statement (annual, 2023-12-31) — Normalized Income: 70884470.00
MD cash_flow (annual, 2023-12-31) — Operating Cash Flow: 137325000.00
MD income_statement (annual, 2023-12-31) — Operating Income: 157852000.00
MD income_statement (annual, 2023-12-31) — Operating Revenue: 1992045000.00
MD balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 84018023.00
MD balance_sheet (annual, 2023-12-31) — Other Current Assets: 12308000.00
MD balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 12500000.00
MD balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2214000.00
MD income_statement (annual, 2023-12-31) — Other Gand A: 227542000.00
MD income_statement (annual, 2023-12-31) — Other Income Expense: -164136000.00
MD balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 21240000.00
MD cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1928000.00
MD balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 82165000.00
MD balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 281836000.00
MD balance_sheet (annual, 2023-12-31) — Other Properties: 278330000.00
MD balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 104485000.00
MD balance_sheet (annual, 2023-12-31) — Payables: 73292000.00
MD balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 352957000.00
MD balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
MD balance_sheet (annual, 2023-12-31) — Prepaid Assets: 13525000.00
MD income_statement (annual, 2023-12-31) — Pretax Income: -48359000.00
MD balance_sheet (annual, 2023-12-31) — Properties: 0.00
MD cash_flow (annual, 2023-12-31) — Purchase Of Business: -6667000.00
MD cash_flow (annual, 2023-12-31) — Purchase Of Investment: -31893000.00
MD cash_flow (annual, 2023-12-31) — Purchase Of PPE: -33328000.00
MD balance_sheet (annual, 2023-12-31) — Receivables: 279878000.00
MD income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1573075000.00
MD income_statement (annual, 2023-12-31) — Reconciled Depreciation: 36171000.00
MD cash_flow (annual, 2023-12-31) — Repayment Of Debt: -489118000.00
MD cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -919000.00
MD income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 2219000.00
MD balance_sheet (annual, 2023-12-31) — Retained Earnings: -149471000.00
MD cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
MD cash_flow (annual, 2023-12-31) — Sale Of Investment: 22905000.00
MD cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
MD income_statement (annual, 2023-12-31) — Selling General And Administration: 227542000.00
MD balance_sheet (annual, 2023-12-31) — Share Issued: 84018023.00
MD income_statement (annual, 2023-12-31) — Special Income Charges: -170531000.00
MD cash_flow (annual, 2023-12-31) — Stock Based Compensation: 12323000.00
MD balance_sheet (annual, 2023-12-31) — Stockholders Equity: 849061000.00
MD balance_sheet (annual, 2023-12-31) — Tangible Book Value: -556345000.00
MD income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -34900530.00
MD income_statement (annual, 2023-12-31) — Tax Provision: 12049000.00
MD income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
MD balance_sheet (annual, 2023-12-31) — Taxes Receivable: 7565000.00
MD balance_sheet (annual, 2023-12-31) — Total Assets: 2219810000.00
MD balance_sheet (annual, 2023-12-31) — Total Capitalization: 1460654000.00
MD balance_sheet (annual, 2023-12-31) — Total Debt: 701648000.00
MD balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 849061000.00
MD income_statement (annual, 2023-12-31) — Total Expenses: 1836788000.00
MD balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1370749000.00
MD balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1736356000.00
MD balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 981803000.00
MD income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 7321000.00
MD balance_sheet (annual, 2023-12-31) — Total Tax Payable: 38704000.00
MD income_statement (annual, 2023-12-31) — Total Unusual Items: -166193000.00
MD income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -166193000.00
MD balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
MD balance_sheet (annual, 2023-12-31) — Working Capital: 94508000.00
MD income_statement (annual, 2023-12-31) — Write Off: 20000000.00
MD balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -1182779000.00
MD cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
MD cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 48763000.00
MD cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: -4208000.00
MD cash_flow (quarterly, 2024-09-30) — Change In Payable: 44555000.00
MD cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: -4208000.00
MD cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 59000.00
MD income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: -59000.00
MD balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 1469676000.00
MD income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
MD cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 59000.00
MD income_statement (annual, 2024-12-31) — +Operating Expense: 270663000.00
MD income_statement (annual, 2024-12-31) — +Total Revenue: 2012919000.00
MD balance_sheet (annual, 2024-12-31) — Accounts Payable: 46431000.00
MD balance_sheet (annual, 2024-12-31) — Accounts Receivable: 259990000.00
MD balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -126507000.00
MD balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -126507000.00
MD balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1013690000.00
MD balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1075145000.00
MD balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1075145000.00
MD cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 178435000.00
MD cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -3599000.00
MD income_statement (annual, 2024-12-31) — Basic Average Shares: 85866000.00
MD income_statement (quarterly, 2024-12-31) — Basic Average Shares: 85866000.00
MD income_statement (annual, 2024-12-31) — Basic EPS: -1.15
MD income_statement (quarterly, 2024-12-31) — Basic EPS: 0.35
MD cash_flow (annual, 2024-12-31) — Beginning Cash Position: 73258000.00
MD balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 8286000.00
MD balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 8286000.00
MD cash_flow (annual, 2024-12-31) — Capital Expenditure: -22022000.00
MD balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 49990000.00
MD balance_sheet (annual, 2024-12-31) — Capital Stock: 859000.00
MD balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 229940000.00
MD balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 348506000.00
MD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -14485000.00
MD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -35406000.00
MD cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 217250000.00
MD cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -10677000.00
MD cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 33728000.00
MD cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5381000.00
MD cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -5037000.00
MD cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 51140000.00
MD cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3497000.00
MD cash_flow (annual, 2024-12-31) — Change In Receivables: 10292000.00
MD cash_flow (annual, 2024-12-31) — Change In Working Capital: 88239000.00
MD cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 10292000.00
MD cash_flow (annual, 2024-12-31) — Changes In Cash: 156682000.00
MD balance_sheet (annual, 2024-12-31) — Common Stock: 859000.00
MD balance_sheet (annual, 2024-12-31) — Common Stock Equity: 764938000.00
MD cash_flow (annual, 2024-12-31) — Common Stock Issuance: 3638000.00
MD cash_flow (annual, 2024-12-31) — Common Stock Payments: -1703000.00
MD income_statement (annual, 2024-12-31) — Cost Of Revenue: 1558575000.00
MD balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 316809000.00
MD balance_sheet (annual, 2024-12-31) — Current Assets: 639607000.00
MD balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 14499000.00
MD balance_sheet (annual, 2024-12-31) — Current Debt: 18750000.00
MD balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 33249000.00
MD balance_sheet (annual, 2024-12-31) — Current Liabilities: 434110000.00
MD cash_flow (annual, 2024-12-31) — Deferred Income Tax: -2130000.00
MD cash_flow (annual, 2024-12-31) — Deferred Tax: -2130000.00
MD cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 32226000.00
MD income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 32226000.00
MD cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 32226000.00
MD income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 32226000.00
MD income_statement (annual, 2024-12-31) — Diluted Average Shares: 85866000.00
MD income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 85866000.00
MD income_statement (annual, 2024-12-31) — Diluted EPS: -1.19
MD income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.35
MD income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -99069000.00
MD income_statement (annual, 2024-12-31) — EBIT: -60598000.00
MD income_statement (annual, 2024-12-31) — EBITDA: -28372000.00
MD income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 2344000.00
MD cash_flow (annual, 2024-12-31) — End Cash Position: 229940000.00
MD cash_flow (annual, 2024-12-31) — Financing Cash Flow: -14485000.00
MD cash_flow (annual, 2024-12-31) — Free Cash Flow: 184551000.00
MD cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 9699000.00
MD cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -1233000.00
MD income_statement (annual, 2024-12-31) — Gain On Sale Of Business: -9699000.00
MD income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 1233000.00
MD income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 5771000.00
MD balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1071000.00
MD income_statement (annual, 2024-12-31) — General And Administrative Expense: 238437000.00
MD balance_sheet (annual, 2024-12-31) — Goodwill: 1242606000.00
MD balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1254201000.00
MD balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1335135000.00
MD balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 1335135000.00
MD balance_sheet (annual, 2024-12-31) — Gross PPE: 204946000.00
MD income_statement (annual, 2024-12-31) — Gross Profit: 454344000.00
MD income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 178435000.00
MD income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: -3599000.00
MD cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 4673000.00
MD balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2171000.00
MD income_statement (annual, 2024-12-31) — Interest Expense: 40743000.00
MD income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 40743000.00
MD cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 40003000.00
MD balance_sheet (annual, 2024-12-31) — Interest Payable: 8159000.00
MD balance_sheet (annual, 2024-12-31) — Invested Capital: 1377261000.00
MD cash_flow (annual, 2024-12-31) — Investing Cash Flow: -35406000.00
MD cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 3638000.00
MD cash_flow (annual, 2024-12-31) — Issuance Of Debt: 235500000.00
MD cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MD balance_sheet (annual, 2024-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 2032000.00
MD balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 35491000.00
MD balance_sheet (annual, 2024-12-31) — Long Term Debt: 593573000.00
MD balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 629064000.00
MD cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 235500000.00
MD cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
MD cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -250888000.00
MD income_statement (annual, 2024-12-31) — Minority Interests: 0.00
MD cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -8167000.00
MD cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1935000.00
MD balance_sheet (annual, 2024-12-31) — Net Debt: 382383000.00
MD income_statement (annual, 2024-12-31) — Net Income: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
MD income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -99069000.00
MD cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -99069000.00
MD income_statement (annual, 2024-12-31) — Net Interest Income: -40743000.00
MD cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -12052000.00
MD cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -15388000.00
MD cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -15388000.00
MD income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -40743000.00
MD cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1032000.00
MD cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1084000.00
MD cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 6835000.00
MD balance_sheet (annual, 2024-12-31) — Net PPE: 78439000.00
MD cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -22022000.00
MD balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -489263000.00
MD balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 103855000.00
MD balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 34246000.00
MD balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 103855000.00
MD balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 34246000.00
MD income_statement (annual, 2024-12-31) — Normalized EBITDA: 218251000.00
MD income_statement (annual, 2024-12-31) — Normalized Income: 142029644.80
MD cash_flow (annual, 2024-12-31) — Operating Cash Flow: 206573000.00
MD cash_flow (annual, 2024-12-31) — Operating Gains Losses: 9699000.00
MD cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -1233000.00
MD income_statement (annual, 2024-12-31) — Operating Income: 183681000.00
MD income_statement (annual, 2024-12-31) — Operating Revenue: 2010288000.00
MD balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 85866000.00
MD balance_sheet (annual, 2024-12-31) — Other Current Assets: 5087000.00
MD balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 18750000.00
MD balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1071000.00
MD income_statement (annual, 2024-12-31) — Other Gand A: 238437000.00
MD income_statement (annual, 2024-12-31) — Other Income Expense: -244279000.00
MD balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11595000.00
MD cash_flow (annual, 2024-12-31) — Other Non Cash Items: -2018000.00
MD balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 76598000.00
MD balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 290342000.00
MD balance_sheet (annual, 2024-12-31) — Other Properties: 194628000.00
MD balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 118566000.00
MD balance_sheet (annual, 2024-12-31) — Payables: 84052000.00
MD balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 400861000.00
MD balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MD balance_sheet (annual, 2024-12-31) — Prepaid Assets: 13410000.00
MD income_statement (annual, 2024-12-31) — Pretax Income: -101341000.00
MD balance_sheet (annual, 2024-12-31) — Properties: 0.00
MD balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MD cash_flow (annual, 2024-12-31) — Purchase Of Business: -8167000.00
MD cash_flow (annual, 2024-12-31) — Purchase Of Investment: -64546000.00
MD cash_flow (annual, 2024-12-31) — Purchase Of PPE: -22022000.00
MD balance_sheet (annual, 2024-12-31) — Receivables: 272604000.00
MD income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1558575000.00
MD income_statement (annual, 2024-12-31) — Reconciled Depreciation: 32226000.00
MD cash_flow (annual, 2024-12-31) — Repayment Of Debt: -250888000.00
MD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1703000.00
MD income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 64260000.00
MD balance_sheet (annual, 2024-12-31) — Retained Earnings: -248540000.00
MD cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
MD cash_flow (annual, 2024-12-31) — Sale Of Investment: 52494000.00
MD income_statement (annual, 2024-12-31) — Selling General And Administration: 238437000.00
MD balance_sheet (annual, 2024-12-31) — Share Issued: 85866000.00
MD income_statement (annual, 2024-12-31) — Special Income Charges: -252394000.00
MD cash_flow (annual, 2024-12-31) — Stock Based Compensation: 11868000.00
MD balance_sheet (annual, 2024-12-31) — Stockholders Equity: 764938000.00
MD balance_sheet (annual, 2024-12-31) — Tangible Book Value: -489263000.00
MD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5524355.20
MD income_statement (annual, 2024-12-31) — Tax Provision: -2272000.00
MD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
MD balance_sheet (annual, 2024-12-31) — Taxes Receivable: 12614000.00
MD balance_sheet (annual, 2024-12-31) — Total Assets: 2152700000.00
MD balance_sheet (annual, 2024-12-31) — Total Capitalization: 1358511000.00
MD balance_sheet (annual, 2024-12-31) — Total Debt: 662313000.00
MD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 764938000.00
MD income_statement (annual, 2024-12-31) — Total Expenses: 1829238000.00
MD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1387762000.00
MD balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1513093000.00
MD balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 953652000.00
MD income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -68713000.00
MD balance_sheet (annual, 2024-12-31) — Total Tax Payable: 37621000.00
MD income_statement (annual, 2024-12-31) — Total Unusual Items: -246623000.00
MD income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -246623000.00
MD balance_sheet (annual, 2024-12-31) — Working Capital: 205497000.00
MD income_statement (annual, 2024-12-31) — Write Off: 0.00
MD income_statement (quarterly, 2025-03-31) — +Operating Expense: 63936000.00
MD income_statement (quarterly, 2025-03-31) — +Total Revenue: 458359000.00
MD balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 44120000.00
MD balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 242529000.00
MD balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1016425000.00
MD income_statement (quarterly, 2025-03-31) — Basic Average Shares: 85810408.00
MD income_statement (quarterly, 2025-03-31) — Basic EPS: 0.24
MD cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 229940000.00
MD cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3318000.00
MD balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 42712000.00
MD balance_sheet (quarterly, 2025-03-31) — Capital Stock: 858000.00
MD balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 98978000.00
MD balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 219176000.00
MD balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 4348000.00
MD balance_sheet (quarterly, 2025-03-31) — Cash Financial: 94630000.00
MD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -6035000.00
MD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -7464000.00
MD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -116111000.00
MD cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -1352000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -159685000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 2748000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 4649000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -13739000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Payable: -156937000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -156937000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1125000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Receivables: 17461000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 2748000.00
MD cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -149691000.00
MD cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 17461000.00
MD cash_flow (quarterly, 2025-03-31) — Changes In Cash: -130962000.00
MD balance_sheet (quarterly, 2025-03-31) — Common Stock: 858000.00
MD balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 789188000.00
MD cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 662000.00
MD cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1569000.00
MD income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 355717000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 164678000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Assets: 491670000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 12174000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Debt: 22128000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 34302000.00
MD balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 271052000.00
MD cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 4398000.00
MD cash_flow (quarterly, 2025-03-31) — Deferred Tax: 4398000.00
MD cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5332000.00
MD income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 5332000.00
MD cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5332000.00
MD income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 5332000.00
MD income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 85810408.00
MD income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.24
MD income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 20737000.00
MD income_statement (quarterly, 2025-03-31) — EBIT: 37244000.00
MD income_statement (quarterly, 2025-03-31) — EBITDA: 42576000.00
MD income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 406000.00
MD cash_flow (quarterly, 2025-03-31) — End Cash Position: 98978000.00
MD cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -6035000.00
MD cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -120781000.00
MD income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 4737000.00
MD balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -292000.00
MD income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 58604000.00
MD balance_sheet (quarterly, 2025-03-31) — Goodwill: 1242606000.00
MD balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1252993000.00
MD balance_sheet (quarterly, 2025-03-31) — Gross PPE: 78088000.00
MD income_statement (quarterly, 2025-03-31) — Gross Profit: 102642000.00
MD balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 2577000.00
MD income_statement (quarterly, 2025-03-31) — Interest Expense: 9154000.00
MD income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 9154000.00
MD balance_sheet (quarterly, 2025-03-31) — Interest Payable: 2782000.00
MD balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1401792000.00